Table 2. Endometritis 30 days following treatment with cefoxitin and doxycycline and short-term treatment failure (endometritis at 30 days and persistent pelvic pain) among women with and without baseline Mycoplasma genitalium (MG) genital tract infection.

Outcome	Cervical and/or endometrial Mg+ n (%) n = 88		Cervical and/or endometrial Mg− n (%) n = 498	Adjusted RR¶ (95% CI)	Endometrial Mg+ n (%) n = 50	Endometrial Mg− n (%) n = 561	Adjusted RR¶ (95% CI)
Treatment failure*	8 (40.0)	26 (17.5)		2.6 (0.8 to 8.9)	6 (50.0)	30 (18.5)	4.6 (1.1 to 20.1)
Endometritis at 30 days†	25 (56.8)	119 (39.0)		1.9 (0.9 to 3.9)	19 (70.4)	131 (39.2)	4.0 (1.5 to 10.9)
Incident endometritis‡	6 (24.0)	35 (15.8)		1.5 (0.4 to 5.0)	5 (38.5)	37 (15.4)	5.0 (1.2 to 20.6)
Persistent endometritis§	17 (47.2)	73 (28.2)		2.1 (1.0 to 4.6)	13 (61.9)	82 (28.8)	4.1 (1.4 to 11.9)

*Treatment failure is defined as both endometritis and pelvic pain present at the 30 day clinic visit; †All women categorised as having endometritis at the 30 day clinic visit; ‡includes women without endometritis at baseline who are categorised as having endometritis at the 30 day clinic visit; §includes women who are categorised as having endometritis at both baseline and 30 days; ¶Adjusted for age and race, self reported partner treatment and intercourse between baseline and the 30 day clinic visit.